Afghanistan: MSF hospital in Kandahar provides hope for people with TB
Jawahira was referred to the Doctors Without Borders/Médecins Sans Frontières (MSF) tuberculosis (TB) hospital in Kandahar earlier this year from a clinic in Daikundi, central Afghanistan. “I used to visit private clinics, but instead of giving me TB medication, they usually just prescribed me painkillers,” she says.
The cost of searching out treatment also took its toll. “My home is far away in Uruzgan, so when we went to see a doctor, I had to spend 6,000 Afghani (US$67) for the car fare and then 13,000 (US$146) for the drugs they gave me.”
The sum spent by Jawahira on each visit to the doctor is about one-third of the average monthly income in Afghanistan. According to the World Bank, an estimated 60 per cent of the country’s population are out of work and receive no income at all, while the effect of sanctions, combined with additional financial measures against the government of the Islamic Emirate of Afghanistan (IEA), are being felt nationwide. People often struggle to afford even basic food items, let alone travel expenses and medical fees for hospital visits. Meanwhile, the public healthcare system is under-resourced, under-staffed and under-funded.
Jawahira’s story is just one of many told by MSF patients that show how, all too often, Afghanistan’s broken economy and dysfunctional healthcare system leave people who need advanced medical treatment without any reasonable options. Either they plunge themselves into debt, or they settle for visiting a health facility which they can afford, but where the quality of care may be less good.
MSF’s 24-bed TB hospital in Kandahar is the only medical facility providing advanced TB care in southern Afghanistan. Patients come from the nearby provinces of Helmand, Uruzgan, Nimroz and Zabul, but others travel from up to 350 kilometres away, from Farah, Dikondi, Badghis, Ghazni and Paktika provinces. “Our catchment area is so big, impossible to know exactly how many people are in it,” says MSF medical advisor Allieu Tommy. “Many travel from afar, and we support them by paying for transport costs, housing expenses and food alleviate some of the economic burden.” Without such incentives, most patients afford to come for treatment.
Lack of awareness about TB
Difficulties reaching and affording medical care are not the only barriers to TB treatment faced by people in Afghanistan. Another is the widespread lack of knowledge about the disease.
“Our daughter Bibi is nine years old and has been sick since childhood, but we did not know of her illness – we had never heard the name TB before,” says her father Hamdullah.
MSF teams carry out regular health promotion activities in local communities in Kandahar to improve people’s understanding of TB. They also provide information about TB to patients and caretakers at the hospital in Kandahar. “When a person arrives for the first time and learns that they have TB, we talk to them about what TB is, how it’s transmitted, how to be careful around their family members, and how long the treatment will take,” explains MSF nurse Taiba Azizi.
Providing this information is simple but effective. “Now I understand the symptoms and people back home know it is a dangerous disease,” says Hamdullah. “If somebody had seen her [Bibi] earlier, they would have said she would not recover. But now, we know she past this. She has already started to eat and walk. We hope she is getting better.”
MSF also tests patients’ family members for TB, as the disease is highly transmissible, particularly when people live close together.
Some patients have a form of the disease that is resistant to conventional TB drugs and require treatment that lasts from nine to 12 months. This can be especially difficult to cope with whilst in a hospital and far from friends and relatives. As a result, many patients fail to see their treatment through to the end. But following excellent research results, in 2023 a six-month short course regimen will be introduced that should make it easier for people to finish their treatment.
MSF has already set up a DR-TB program that combines specialist inpatient care with supervised home-based treatment to help patients better cope with the regimens. “What we offer is a system whereby a person spends the first 30 days in our facility under careful observation and, if they experience major adverse side effects from the drugs taken, they are discharged for homecare,” says Azizi. “Our staff then do weekly follow-ups with them over the phone, meaning that patients only need to come back to the hospital once a month to renew their medications and have an in-person consultation.”
Women and children are most vulnerable to TB
Over 70 per cent of patients in MSF’s Kandahar TB hospital are women and children. “Women and children stay at home in dusty, poorly ventilated rooms for longer periods of time than men,” says Tommy. “If a woman gets infected, the children are likely to catch the disease as well. Other cultural factors play a role too. Women whisper or speak in very low tones to one another, especially if men are in the room. Respiratory tract infections are then easily transmissible due to their proximity.”
An additional challenge for female patients is that they are generally required to be accompanied by a male family member to the hospital, and this coupled with the economic barriers can significantly reduce their access to healthcare.
It is estimated that tuberculosis and its resistant forms kill more than 13,000 people in Afghanistan every year. Access to proper care remains a major challenge for patients in the southern part of the country, mainly due to insufficient medical infrastructure, length of treatment and financial obstacles. And while MSF’s TB hospital in Kandahar provides quality and free treatment for many, it cannot be seen as a long-term solution. The people of Afghanistan need a health system that meets their needs.
MSF’s Kandahar TB hospital aims to provide patients with quality, free and effective treatment. The hospital has a laboratory, an outpatient clinic and 24 beds for patients with DR-TB and comorbidities, and for those who develop severe side effects after taking DR-TB medication. MSF teams have provided more than 13,000 consultations for patients with drug-sensitive and drug-resistant TB so far this year and admitted more than 70 patients for inpatient treatment.
MSF also provides patients with mental health support, carries out health promotion activities within the hospital and in the surrounding area and delivers technical and financial support to provincial laboratories that offer TB testing.